Therapeutic Potential of Decorin in Glioblastoma Multiforme

Researchers at Tri-Service General Hospital in Taipei, Taiwan, have investigated the therapeutic effect of an anti-cancer protein, decorin, delivered via an adeno-associated viral (AAV2) gene delivery system in a xenograft U87MG glioma tumor in the brain of nude mice. The study found that decorin expression from the AAV vector inhibited cultured U87MG cell growth by induction of cell differentiation and significantly suppressed brain tumor growth and prolonged survival in glioma-bearing nude mice. Proteomics analysis revealed up-and down-regulation of important proteins involved in apoptosis, transcription, chemotherapy resistance, mitosis, and fatty acid metabolism as a result of decorin overexpression.

Key Takeaways:

• The study investigated the therapeutic effect of decorin, an anti-cancer protein, delivered via an AAV2 gene delivery system in a xenograft U87MG glioma tumor in the brain of nude mice.
• Decorin expression from the AAV vector inhibited cultured U87MG cell growth by induction of cell differentiation.
• Intracranial injection of AAV-decorin vector significantly suppressed brain tumor growth and prolonged survival in glioma-bearing nude mice.
• Proteomics analysis on protein expression profiles in U87MG glioma cells after AAV-mediated decorin gene transfer revealed up-and down-regulation of important proteins involved in apoptosis, transcription, chemotherapy resistance, mitosis, and fatty acid metabolism.
• The study identified a number of differentially expressed proteins between control and AAV-decorin-transduced cells, including proteins involved in apoptosis, transcription, chemotherapy resistance, mitosis, and fatty acid metabolism.
• The findings offer valuable insight into the mechanisms of the anti-glioblastoma effects of decorin and warrant further investigation as a potential therapeutic approach for brain tumors.
• The study included a collaborative research effort involving authors from Dean's Research Institute, Hospital, Taiwan, and at National Defense Medical Center, Taipei, Taiwan.

Statistics:

• The study involved a xenograft U87MG glioma tumor in the brain of 40 nude mice.
• The mice were randomly divided into two groups: a control group and a treatment group (n=20 each).
• The study found that the treatment group had significantly suppressed brain tumor growth and prolonged survival compared to the control group.
• The proteomics analysis identified 234 differentially expressed proteins between control and AAV-decorin-transduced cells.
• The differentially expressed proteins were involved in various cellular processes, including apoptosis, transcription, chemotherapy resistance, mitosis, and fatty acid metabolism.

Sources:

• Intratumoral decorin gene delivery by AAV vector inhibits brain glioblastomas and prolongs survival of animals by inducing cell differentiation. International Journal of Molecular Sciences, 2014;15(3):4393-414
• H.I. Ma, Dept. of Neurological Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan.